OSTX Total Other Income Expense Net from 2010 to 2025

OSTX Stock   2.60  0.10  4.00%   
OS Therapies Total Other Income Expense Net yearly trend continues to be fairly stable with very little volatility. Total Other Income Expense Net will likely drop to about -3.3 M in 2025. During the period from 2010 to 2025, OS Therapies Total Other Income Expense Net regression line of annual values had r-squared of  0.65 and arithmetic mean of (887,981). View All Fundamentals
 
Total Other Income Expense Net  
First Reported
2010-12-31
Previous Quarter
-3.1 M
Current Value
-3.3 M
Quarterly Volatility
1.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check OS Therapies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OS Therapies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.1 K, Selling General Administrative of 1 M or Other Operating Expenses of 3.7 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. OSTX financial statements analysis is a perfect complement when working with OS Therapies Valuation or Volatility modules.
  
Check out the analysis of OS Therapies Correlation against competitors.

Latest OS Therapies' Total Other Income Expense Net Growth Pattern

Below is the plot of the Total Other Income Expense Net of OS Therapies Incorporated over the last few years. It is OS Therapies' Total Other Income Expense Net historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in OS Therapies' overall financial position and show how it may be relating to other accounts over time.
Total Other Income Expense Net10 Years Trend
Slightly volatile
   Total Other Income Expense Net   
       Timeline  

OSTX Total Other Income Expense Net Regression Statistics

Arithmetic Mean(887,981)
Geometric Mean6,127
Coefficient Of Variation(157.87)
Mean Deviation1,220,450
Median(380.50)
Standard Deviation1,401,865
Sample Variance2T
Range3.4M
R-Value(0.81)
Mean Square Error735.5B
R-Squared0.65
Significance0.0002
Slope(237,521)
Total Sum of Squares29.5T

OSTX Total Other Income Expense Net History

2025-3.3 M
2024-3.1 M
2023-3.4 M
2022-1.8 M
2021-2.6 M

About OS Therapies Financial Statements

OS Therapies investors use historical fundamental indicators, such as OS Therapies' Total Other Income Expense Net, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in OS Therapies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Other Income Expense Net-3.1 M-3.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for OSTX Stock Analysis

When running OS Therapies' price analysis, check to measure OS Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OS Therapies is operating at the current time. Most of OS Therapies' value examination focuses on studying past and present price action to predict the probability of OS Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OS Therapies' price. Additionally, you may evaluate how the addition of OS Therapies to your portfolios can decrease your overall portfolio volatility.